Skip to main content
Sports Medicine - Open
Download PDF
  • Original Research Article
  • Open access
  • Published:

Evaluating the Suitability of the Low Energy Availability in Females Questionnaire (LEAF-Q) for Female Football Players

Sports Medicine - Open volume 9, Article number: 54 (2023) Cite this article

Abstract

Background

The Low Energy Availability in Females Questionnaire (LEAF-Q) is a screening tool developed to detect endurance athletes and dancers at risk for development of persistent low energy availability (LEA) and the female athlete triad (Triad). This study investigated the applicability of the LEAF-Q in a cohort of sixty professional female football players.

Methods

The participants were classified as at risk (≥ 8) or not at risk (< 8) for persistent LEA and the Triad according to their LEAF-Q score, before being compared. Receiver operating curves were then conducted to examine the ability of the overall LEAF-Q and subcategories to correctly determine the presence of clinically defined markers of the Triad. Additionally, Youden’s index was calculated to determine the best fitting cut-off values.

Results

Thirty-two percent of participants were classified as at risk by the LEAF-Q. We found no statistically significant differences between the two groups for any markers associated with persistent LEA. Except for acceptable accuracy in determining menstrual status, all other LEAF-Q components exhibited poor accuracy and predictive values. Youden’s index scores imply that increasing the overall and injury cut-off values to ≥ 10 and ≥ 5 respectively, would yield increased performance.

Conclusions

Our findings do not support the use of the LEAF-Q for the purpose of detecting LEA and Triad conditions among female football players.

Key points

  • The LEAF-Q is a screening tool developed to identify female endurance athletes and dancers at risk for development of low energy availability and the female athlete triad. The questionnaire has been used in a wide range of athlete populations, including female football players, without sufficient knowledge about its applicability.

  • The prevalence of acute and impact injuries in football, compared to endurance sports and dancing, may introduce substantial bias, leading to artificially inflated scores on the questionnaire.

  • Our findings do not support the use of the LEAF-Q for the purpose of detecting symptoms of the female athlete triad and LEA among female football players.

Introduction

Energy availability (EA) is defined as the difference between energy intake (EI) and exercise energy expenditure. It is expressed relative to an individual’s fat-free mass (FFM) and represents the residual amount of energy available to sustain all physiological functions [1]. Consequently, low energy availability (LEA) denotes the state where the body receives insufficient energy to optimally perform these functions. Despite emerging evidence indicating individual variation in response to LEA, it is commonly defined as < 30 kcal/kg−1 FFM/day−1 [2]. Persistent or severe LEA are recognized as the etiological underpinning of both the female athlete triad (Triad) and Relative Energy Deficiency in Sport (REDs) [3, 4]. The Triad encompasses three interrelated conditions: EA, menstrual function and bone health, all ranging on a continuum from health to disease, with LEA as a causal factor of Triad dysfunction [5]. The REDs model, however, describes a broader range of potential consequences affecting both health and sports performance among males and females, caused by LEA [3]. Despite discussions regarding the scientific rigor and causal evidence supporting the REDs model [6], it now contributes to the International Olympic Committee’s (IOC) consensus statement and guidelines for supporting athletes’ health [3].

The Low Energy Availability in Females Questionnaire (LEAF-Q) is a screening tool developed for endurance athletes and dancers, and is validated against clinical markers of the Triad and persistent LEA [7]. The LEAF-Q consists of 25 items that assesses three subcategories: injuries, gastrointestinal symptoms, and reproductive/menstrual function, respectively. The original study recommended that additional validation of the questionnaire is necessary before utilizing it beyond the intended population [7]. The clinical utility of the LEAF-Q was recently examined in a mixed-sport cohort of athletes within individual sports, as well as netball and water polo [8]. It was concluded that the LEAF-Q was suitable to “rule out” LEA-related conditions in athletes who scored below the originally published cut-off value, however, it failed to identify athletes “at risk” of the Triad or LEA with its associated symptoms.

Football is characterized by a mixture of high- and low-intensity efforts and actions, and is played on a relatively large pitch (90–120 m length, 45–90 m width) [9]. High-level female players usually cover between 9–11 km during a game [10]. As such, football sets itself apart from the majority of contemporary individual and team sports. Although LEA and its associated symptoms are thought to be most prevalent in endurance and weight-sensitive sports [3], studies have reported a wide range of prevalence estimates among female footballers, depending on the measurement methods applied [11,12,13,14,15,16]. This includes studies employing the LEAF-Q to screen for the Triad and LEA, despite insufficient evidence for its application in this population [12, 13, 17]. As LEA and subsequently REDs may have profound ramifications for athletes’ health and performance, there is a need to investigate the suitability of commonly used measurement instruments among female football players. Therefore, the purpose of this study was to evaluate the applicability of the LEAF-Q as a screening tool for female football players. Using a cohort of professional female football players, we examined the capacity of the LEAF-Q to identify markers associated with the Triad and persistent LEA and to correctly classify players at risk for these conditions.

Methods

Study Design

In the present cross-sectional study, we conducted a comprehensive analysis of multiple clinical markers related to the Triad [7] and previously published literature on the subject [18,19,20,21]. The data collection was conducted between October 2021 and May 2022. Within two weeks each participant completed all measurements across two subsequent days.

Participants

Sixty female football players from three Norwegian teams were included in the study. Eight players were currently representing the Norwegian senior national team, while another eight players represented their designated youth national team. The participants were classified as tier 3 (national level) or 4 (international level) according to the athlete classification framework [22].

Body Composition and BMD

Body composition (% fat mass, FFM) and bone mineral density (BMD) were assessed in a fasting state using Dual-Energy X-Ray Absorptiometry (DXA; Prodigy, Encore, SP 4.1, version 18, GE medical systems, Madison, Wisconsin, USA), according to best practice guidelines [23]. Before completing the scan, body weight (Seca 869, Hamburg, Germany) ± 0.1 kg and height (Seca, Hamburg, Germany) was recorded. Participants, dressed in minimal attire (i.e., tights and t-shirt), were situated in the supine position, ensuring their body was properly aligned with the central longitudinal axis of the scan table. Both arms were positioned alongside the body, in neutral position to minimize overlapping of anatomical structures. Participants first underwent a total body scan for assessment of body composition. This was followed by an anteroposterior scan of the lumbar spine (L1-4) and bilateral hip densitometry to evaluate BMD. Automatic analysis was performed using the manufacturer’s software (Encore, SP 4.1) and manually adjusted if indicated. All measurements and analyses were conducted by the same certified technician to avoid inter-rater variability and error.

Energy Availability

Measures of EA were estimated through resting metabolic rate (RMR). Specifically, RMR < 30 kcal/kg−1 FFM/day−1 or RMRRatio < 0.90 using the measured value, and the Cunningham equation was considered indicative of LEA [24, 25]. RMR is considered a viable option for estimating EA, when used in combination with other markers, as well as being strongly correlated with energy deficiency and amenorrhea in exercising women [26, 27]. Due to significant challenges associated with the direct measurement of EA, and the lack of a gold standard method, it was deemed appropriate to utilize this surrogate marker [28, 29].

RMR was measured with the participants arriving at the test facility by motorized transportation between 06 and 09 a.m. in an overnight fasted state. Participants were placed in a silent room, in the supine position for 5 min, before a ventilated canopy hoodie (Vyntus CPX, CareFusion, Hoechberg, Germany, Sentrysuit v. 2.21.4) was positioned. Oxygen consumption (VO2) and carbon dioxide production (VCO2) were then measured for 25 min, where the average value for the last 20 min was used to assess RMR.

Screening Instruments

Participants filled out the LEAF-Q after completion of RMR and DXA measurement, at the testing facility. The questionnaire was administered with a portable tablet, using a digital encrypted platform (Nettskjema, University of Oslo, Norway). Participants were classified as at risk (total score ≥ 8) or not at risk (< 8) for the Triad, according to the LEAF-Q scoring system [7]. Further, in accordance with the original publication, the LEAF-Q cut-off values associated with increased risk for Triad dysfunction were applied in the same manner (Injuries(≥ 2), gastrointestinal symptoms (≥ 2) and menstrual function (≥ 4)). As LEA may be present with or without disordered eating [30], the participants also completed the Eating Disorder Examination Questionnaire (EDE-Q 11). This has been extensively used to assess self-reported eating behavior pathology [31]. Information on the history of stress fractures, which has been strongly linked with LEA [32], was obtained through a custom-made question that specifically inquired about the injury position and frequency.

Menstrual Function

The LEAF-Q was used to determine menstrual status, i.e., eumenorrheic or amenorrheic (oligomenorrhea was considered as amenorrhea). Menstrual status could not be determined in participants who reported usage of hormonal contraception (55%). As it was not considered ethically acceptable to request cessation of hormonal contraceptive usage, the menstrual status was only classified in 27 of the participants (45%).

Blood Samples

After an overnight fasting period (8–10 h), blood was collected for both plasma and serum samples [33]. These samples were stored in Biobank Haukeland, Laboratory Medicine and Pathology, Haukeland University Hospital, Bergen, Norway, in 3.5 ml serum/gel vacutainers before analyses. Analyses that have either been directly linked to or associated with LEA were assessed. This included glucose, insulin, thyroid stimulating hormone (TSH), free triiodothyronine (T3), free thyroxine (T4), insulin-like growth factor 1 (IGF-1), and leptin, which were analyzed at the Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway. The laboratory is accredited in compliance with ISO 15189:2012. Glucose was analyzed using Cobas 8000, TSH, free T3 and free T4 were measured with Cobas e801. Insulin and IGF-1 were analyzed using Immulite 2000 XPi, whereas leptin was determined using an enzyme-linked immunosorbent assay kit (Mediagnost Cat#E07, RRID: AB_2813737)(non-accredited analysis).

Statistical Analyses

The statistical analyses were conducted using SPSS 28 (IBM, Armonk, NY, USA). Variables being non-normally distributed according to the Shapiro-Wilks test were described using median and range and between group variables examined with nonparametric tests (Mann–Whitney U). Otherwise, parametric tests (Welch’s test for unequal sample size) and mean ± standard deviation (SD) were reported.

Descriptive statistics are provided for the whole sample, as well as separately for participants classified as at risk versus not at risk for symptoms of the Triad, as defined by their LEAF-Q scores. The alpha level was set to < 0.05.

We used receiver operating curve (ROC) analyses to examine the ability of the LEAF-Q to correctly determine the presence of clinically defined markers of the Triad. For this purpose, we report the area under curve (AUC), sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV), as well as the highest Youden’s index [33] locating the best cut-off value for the overall and the subcategory LEAF-Q scores. These sample-derived discriminatory properties and cut-off scores were compared to the original overall and subcategory cut-off scores, as published by the original authors [7]. The AUC estimates the overall capacity of the LEAF-Q to correctly discriminate Triad from non-Triad cases. The AUC value ranges between 0 and 1, with higher values indicating better discrimination. A non-discriminatory test has an AUC of 0.5 (50%), while higher AUC values represent better than random classification with AUC = 1.0 (100%) being perfect. AUC values > 0.70 (70%) are considered as fair, > 0.80 (80%) as good, and above > 0.90 (90%) as excellent. AUC values below 0.5 indicate reciprocal discrimination that is opposite of expected [34].

In the event of significant AUC values, precision recall curves (PRC) were additionally calculated as ROC analyses may be misleading in case of severely imbalanced data sets (e.g., skewed numbers of positive or negative cases) [35]. Since the majority of athletes generally are expected to be non-symptomatic, we were also interested in the ability of the LEAF-Q score to positively predict individuals with markers of LEA. As such, the PRC may provide additional information regarding the questionnaire’s tenability through measures of precision (identical to PPV in ROC) = \(\frac{{{\text{true}}\;{\text{positives}}}}{{\left( {{\text{true}}\;{\text{positives}} + {\text{false}}\;{\text{positives}}} \right)}}\) and recall (identical to sensitivity in ROC) = \(\frac{{{\text{true}}\;{\text{positives}}}}{{{\text{true}}\;{\text{positives + false}}\;{\text{negatives}}}}\). As none of these formulas involve the number of “true negative” (TN) cases, which is expected to constitute most cases in the present sample, the PRC curves are likely less biased due to the extreme skewness the true negative cases represent in the ROC curve.

Two participants were excluded from the respective analyses; one who was not able to provide blood samples (did not meet for the scheduled appointment), and one who could not provide a measure of RMR due to illness.

Results

There were no statistically significant differences between the two groups for any of the clinical markers associated with LEA, however, free T4 had a P-value of 0.05. Descriptive statistics of the sample, which separates the women classified as at risk (LEAF-Q ≥ 8) and not at risk (LEAF-Q < 8) is presented in Table 1.

Table 1 Descriptive data for all participants and stratified into groups (at risk/low risk of LEA) based on LEAF-Q score. Brackets indicate number of participants in the different groups
Full size table

The overall LEAF-Q score had a mean value of 7.0 ± 3.0, whereas the mean values for the subcategories were 3 ± 2.3 (injury), 2 ± 1.7 (gastrointestinal symptoms) and 2 ± 2.4 (menstrual symptoms), respectively. Moreover, 32% were classified as at risk for the triad (LEAF-Q total ≥ 8). For the subcategories, 68%, 55% and 15% scored above the LEAF-Q cut-off score which are associated with LEA in the original publication [6] for injury (≥ 2), gastrointestinal symptoms (≥ 2) and menstrual symptoms (≥ 4), respectively.

For the overall LEAF-Q, the AUC index was poor for the clinical markers RMRRatio, BMDlumbar, BMDhip and RMR < 30 kcal/kg−1 FFM/day−1 (AUC = 0.44 – 0.53), whereas detection of amenorrhea had a good AUC = 0.86. Table 2 provides estimates of sensitivity, specificity, PPV and NPV, respectively. The PRC for amenorrhea showed a precision of 67% and a recall of 75%, indicating a reduction in actual precision compared to the ROC analysis in terms of identifying athletes at risk. Furthermore, the Youden’s index implies that a cut-off score ≥ 10 as opposed to ≥ 8 would be more appropriate for this cohort.

Table 2 Diagnostic performance of the LEAF-Q overall score to identify individuals with clinical indicators of the Triad
Full size table

For the subcategories, the AUC index performed poorly in detecting clinical markers of LEA for BMDhip, EA, and stress fracture (AUC = 0.43–0.47). AUC to detect amenorrhea was excellent (0.93), but fair (0.78) in detecting BMDlumbar, indicating overall good performance for these subcategories (Table 3). The PRC for amenorrhea showed a precision of 70% and a recall of 88%, while BMDlumbar had a precision of 2% and recall of 100%. The Youden’s index implies that an increase in cut-off score to ≥ 5 as opposed to ≥ 4 yield a better accuracy for the injury subcategory.

Table 3 Diagnostic performance of the LEAF-Q subcategories (injury, gastrointestinal symptoms, and menstrual function) to identify individuals with the associated indicators of the Triad, based on the original publication
Full size table

Discussion

The current study aimed to examine the applicability of the LEAF-Q to identify markers associated with the Triad and persistent LEA and correctly identify players at risk for these conditions. In terms of broad indicators associated with LEA, no statistically significant differences were observed between the groups. While T4, an important metabolic regulator, approached significance, this tendency was not resembled by other hormones, such as T3. It is notable that T3, more closely associated with LEA in the literature, is derived from T4, yet did not follow the same trend [36, 37]. It is possible that further reduction in T4 levels could induce changes in T3 within the at risk group, thereby exacerbating their risk for metabolic alterations associated with LEA. Melin et al. found significant differences between groups for several LEA related hormones, including leptin, T3 and glucose [7]. Consequently, our findings align more closely with those of Rogers et al. who found minimal variation in LEA indicators between mixed sport athletes, categorized by the LEAF-Q [8]. Pertaining to our results, the observed uniformity in LEA indicators across the groups is consistent with the general performance of the LEAF-Q in this study.

The overall performance of the LEAF-Q in detecting menstrual dysfunction was commendable, evident by an AUC of 0.86, suggesting that the original cut-off value of ≥ 8 is appropriate for this indicator. However, the questionnaires effectiveness in identifying players presenting with clinical symptoms of the Triad was suboptimal, rarely performing better than guessing by random. Further, among the recalculated cut-off scores, only amenorrhea boasted a Youdens’s index above 50%, demonstrating poor performance for the recalculated cut-off scores as well. This underscores the apparent disconnect between the perceived risk, as determined by the LEAF-Q assessment, and the tangible manifestation of Triad and LEA indicators. It is important to note that the prevalence of positive indicators for Triad and LEA was relatively low in this cohort, which is consistent with previous assumptions [38]. This could partly explain the poor diagnostic performance relative to previous investigations [7, 8]. Despite this, the LEAF-Q was still unable to accurately identify individuals without signs of LEA, strengthening the overall weak performance observed.

For the injury subcategory, the LEAF-Q demonstrated a fair AUC, as well as excellent sensitivity. Nevertheless, the specificity and PPV was very poor, showing that the LEAF-Q would fail to identify individuals with compromised markers, given a higher prevalence of the condition. The mean injury score was 3.0 ± 2.3 in the context of an overall mean score of 7.0 ± 3.8, resulting in a 68% prevalence above the ≥ 2 cut-off value. This indicates a systematic bias toward elevated injury scores among the participants. It is important to note that the LEAF-Q was originally validated for endurance athletes and dancers [7], who primarily experience overuse injuries [39, 40]. Football, on the other hand, is a high-impact sport with potential for both acute and overuse injuries [41]. This crucial distinction is not accounted for by the LEAF-Q, consequently leading to skewed scores and biased results. Furthermore, the gastrointestinal subcategory performance in detecting athletes with Reduced RMRRatio or RMR < 30 kcal/kg−1 FFM/day−1 (LEA) was very poor, with an AUC of 0.45. The original LEAF-Q included gastrointestinal symptoms as this have been reported in female athletes suffering from disordered eating and or eating disorders [42]. It is possible that these disorders are underrepresented in football, thus making gastrointestinal symptoms inappropriate as a clinical marker among female footballers.

Although the prevalence of LEA and REDs is equivocal in female football players, access to a quality screening tool is necessary. A recent investigation revealed that English female football players exhibit insufficient nutritional knowledge and express apprehension regarding carbohydrate consumption [43]. Moreover, the available literature indicates that female football players may not ingest adequate energy amounts to support optimal performance and recovery [11, 15]. Nonetheless, the existing version of the LEAF-Q lacks the necessary predictive capacity for usage among female footballers. The questionnaire was also developed before recent advancements related to REDs, primarily focusing on the causal relationship between LEA, menstrual disorders, and BMD [4, 20]. As such, resources should be allocated to further exploration of reliable surrogate markers in line with future developments. Connected to this, a recent debate has also emerged about the BMD Z-score thresholds for high-impact sports like football. As athletes experiencing high amounts of mechanical loading are expected to have elevated BMD compared to controls, utilizing the same threshold of < -1 might mask potential consequences of persistent LEA in football players [44]. Nevertheless, increasing the BMD threshold to Z-score < 0 did not significantly change or increase the prevalence estimates in our cohort.

A number of participants in the present study were unable to provide direct assessment of EA. Currently, there is no recognized gold standard method to quantify EA and there are significant constraints associated with direct measurement, particularly in intermittent sports [28, 45]. Hence, we decided to apply a surrogate marker to quantify EA, diverging from the approach of the original study. RMR may be prone to confounding factors such as energy status and recent training intensity/volume [46]. Together with assumptions related to RMRRatio, this could potentially affect our results. As a cross-sectional study, outcome variables will reflect the training and match load at the time of testing. The study included several teams, which were tested at different periods during the year (October-May). Limits of the cross-sectional design may therefore, to some extent, be counterbalanced by catching variability of physiological load across seasons and teams. Lastly, due to contraceptive usage among the participants, information about menstrual irregularities could not be attained by all. This raises the risk of underestimating the prevalence of actual amenorrhea in the cohort. This is, however, reflective of the situation in real world settings [47, 48].

Conclusion

In a diverse array of athletic cohorts, the utilization of the LEAF-Q screening tool persists, despite the fact that its validation remains restricted to endurance athletes and dancers. The poor predictive power of the LEAF-Q does not support its use for the purpose of detecting symptoms of the Triad and LEA with its associated symptoms among female football players. Consequently, the present study may serve to reconsider the interpretation of previous findings where the LEAF-Q has been used to estimate the prevalence of the Triad and LEA in populations for which it has not been validated. Future development of health screening tools for football players should consider the impact and injury mechanisms, as compared to non-contact sports.

Availability of Data and Materials

Any data requests can be directed to the corresponding author upon reasonable request.

Abbreviations

EA:

Energy availability

EI:

Energy intake

FFM:

Fat free mass

LEA:

Low energy availability

REDs:

Relative energy deficiency in sport

TRIAD:

The female athlete triad

LEAF-Q:

Low energy availability in female questionnaire

BMD:

Bone mass density

DXA:

Dual-energy X-ray absorptiometry

RMR:

Resting metabolic rate

T3 :

Triiodothyronine

T4 :

Thyroxine

ROC:

Receiver operator curve

AUC:

Area under the curve

PPV:

Positive predictive value

NPV:

Negative predictive value

PRC:

Precision recall curve

TSH:

Thyroid stimulating hormone

IGF-1:

Insulin-like growth factor 1

EDE-Q:

Eating disorder examination questionnaire

BMI:

Body mass index

References

  1. Loucks AB, Kiens B, Wright HH. Energy availability in athletes. J Sports Sci. 2011;29(sup1):S7–15.

    Article  PubMed  Google Scholar 

  2. Taylor HL, Garabello G, Pugh J, Morton J, Langan-Evans C, Louis J, et al. Patterns of energy availability of free-living athletes display day-to-day variability that is not reflected in laboratory-based protocols: Insights from elite male road cyclists. J Sports Sci. 2022;5:1–8.

    Google Scholar 

  3. Mountjoy M, Sundgot-Borgen J, Burke L, Carter S, Constantini N, Lebrun C, et al. The IOC consensus statement: beyond the female athlete triad—relative energy deficiency in sport (RED-S). Br J Sports Med. 2014;48(7):491–7.

    Article  PubMed  Google Scholar 

  4. Nattiv A, Loucks AB, Manore MM, Sanborn CF, Sundgot-Borgen J, Warren MP. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc. 2007;39(10):1867–82.

    PubMed  Google Scholar 

  5. De Souza MJ, Nattiv A, Joy E, Misra M, Williams NI, Mallinson RJ, et al. 2014 Female Athlete Triad Coalition Consensus Statement on treatment and return to play of the female athlete triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013. Exerc Sport Sci Rev. 2014;48(4):289

  6. Williams NI, Koltun KJ, Strock NCA, De Souza MJ. Female athlete triad and relative energy deficiency in sport: a focus on scientific rigor. Exerc Sport Sci Rev. 2019;47(4):197–205.

    Article  PubMed  Google Scholar 

  7. Melin A, Tornberg AB, Skouby S, Faber J, Ritz C, Sjödin A, et al. The LEAF questionnaire: a screening tool for the identification of female athletes at risk for the female athlete triad. Br J Sports Med. 2014;48(7):540–5.

    Article  PubMed  Google Scholar 

  8. Rogers MA, Drew MK, Appaneal R, Lovell G, Lundy B, Hughes D, et al. The utility of the low energy availability in females questionnaire to detect markers consistent with low energy availability-related conditions in a mixed-sport cohort. Int J Sport Nutr Exerc Metab. 2021;31(5):427–37.

    Article  PubMed  Google Scholar 

  9. Stølen T, Chamari K, Castagna C, Wisløff U. Physiology of soccer. Sports Med. 2005;35(6):501–36.

    Article  PubMed  Google Scholar 

  10. Winther AK, Baptista I, Pedersen S, Randers MB, Johansen D, Krustrup P, et al. Position specific physical performance and running intensity fluctuations in elite women’s football. Scand J Med Sci Sports. 2022;32:105–14.

    Article  PubMed  Google Scholar 

  11. Morehen JC, Rosimus C, Cavenagh BP, Hambly C, Speakman JR, Elliot-Sale KJ, et al. Energy expenditure of female international standard soccer players: a doubly labeled water investigation. Med Sci Sports Exerc. 2022;54(5):769–79.

    Article  PubMed  Google Scholar 

  12. Moss SL, Randell RK, Burgess D, Ridley S, ÓCairealláin C, Allison R, et al. Assessment of energy availability and associated risk factors in professional female soccer players. Eur J Sport Sci. 2020;6:1–10.

    Google Scholar 

  13. Magee MK, Lockard BL, Zabriskie HA, Schaefer AQ, Luedke JA, Erickson JL, et al. Prevalence of low energy availability in collegiate women soccer athletes. J Funct Morphol Kinesiol. 2020;5(4):96.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Dobrowolski H, Wlodarek D. Low energy availability in group of Polish female soccer players. Rocz Panstw Zaki Hig. 2020;71(1):214.

    Google Scholar 

  15. Dasa MS, Friborg O, Kristoffersen M, Pettersen G, Plasqui G, Sundgot-Borgen JK, et al. Energy expenditure, dietary intake and energy availability in female professional football players. BMJ Open Sport Exerc Med. 2023;9(1):e001553.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Braun H, von Andrian-Werburg J, Schänzer W, Thevis M. Nutrition status of young elite female German football players. Pediatr Exerc Sci. 2018;30(1):157–67.

    Article  PubMed  Google Scholar 

  17. Łuszczki E, Jagielski P, Bartosiewicz A, Kuchciak M, Dereń K, Stolarczyk A, et al. The LEAF questionnaire is a good screening tool for the identification of the female athlete triad/relative energy deficiency in sport among young football players. PeerJ. 2021;9:e12118.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Rogers MA, Appaneal RN, Hughes D, Vlahovich N, Waddington G, Burke LM, et al. Prevalence of impaired physiological function consistent with Relative Energy Deficiency in Sport (RED-S): an Australian elite and pre-elite cohort. Br J Sports Med. 2021;55(1):38–45.

    Article  PubMed  Google Scholar 

  19. Elliott-Sale KJ, Tenforde AS, Parziale AL, Holtzman B, Ackerman KE. Endocrine effects of relative energy deficiency in sport. Int J Sport Nutr Exerc Metab. 2018;28(4):335–49.

    Article  CAS  PubMed  Google Scholar 

  20. Mountjoy M, Sundgot-Borgen JK, Burke LM, Ackerman KE, Blauwet C, Constantini N, et al. IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update. Br J Sports Med. 2018;52(11):687–97.

    Article  PubMed  Google Scholar 

  21. De Souza MJ, Koltun KJ, Etter CV, Southmayd EA. Current status of the female athlete triad: update and future directions. Curr Osteoporos Rep. 2017;15(6):577–87.

    Article  PubMed  Google Scholar 

  22. McKay AKA, Stellingwerff T, Smith ES, Martin DT, Mujika I, Goosey-Tolfrey VL, et al. Defining training and performance caliber: a participant classification framework. Int J Sports Physiol Perform. 2022;17(2):317–31.

    Article  PubMed  Google Scholar 

  23. Nana A, Slater GJ, Stewart AD, Burke LM. Methodology Review: Using dual-energy x-ray absorptiometry (DXA) for the assessment of body composition in athletes and active people. Int J Sport Nutr Exerc Metab. 2015;25(2):198–215.

    Article  PubMed  Google Scholar 

  24. Cunningham JJ. Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation. Am J Clin Nutr. 1991;54(6):963–9.

    Article  CAS  PubMed  Google Scholar 

  25. Jagim AR, Camic CL, Kisiolek J, Luedke J, Erickson J, Jones MT, et al. Accuracy of resting metabolic rate prediction equations in athletes. J Strength Cond Res. 2018;32(7):1875–81.

    Article  PubMed  Google Scholar 

  26. Sterringer T, Larson-Meyer DE. RMR ratio as a surrogate marker for low energy availability. Curr Nutr Rep. 2022;11(2):263–72.

    Article  PubMed  Google Scholar 

  27. Strock NCA, Koltun KJ, Southmayd EA, Williams NI, De Souza MJ. Indices of resting metabolic rate accurately reflect energy deficiency in exercising women. Int J Sport Nutr Exerc Metab. 2020;30(1):14–24.

    Article  CAS  PubMed  Google Scholar 

  28. Burke LM, Lundy B, Fahrenholtz IL, Melin AK. Pitfalls of conducting and interpreting estimates of energy availability in free-living athletes. Int J Sport Nutr Exerc Metab. 2018;28(4):350.

    Article  PubMed  Google Scholar 

  29. Heikura IA, Stellingwerff T, Areta JL. Low energy availability in female athletes: From the lab to the field. Eur J Sport Sci. 2021;5:1–11.

    Google Scholar 

  30. Areta JL, Taylor HL, Koehler K. Low energy availability: history, definition and evidence of its endocrine, metabolic and physiological effects in prospective studies in females and males. Eur J Sport Sci. 2021;121(1):1–21.

    Google Scholar 

  31. Friborg O, Reas DL, Rosenvinge JH, Rø Ø. Core pathology of eating disorders as measured by the Eating Disorder Examination Questionnaire (EDE-Q): the predictive role of a nested general (g) and primary factors. Int J Methods Psychiatr Res. 2013;22(3):195–203.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Heikura IA, Uusitalo AL, Stellingwerff T, Bergland D, Mero AA, Burke LM. Low energy availability is difficult to assess but outcomes have large impact on bone injury rates in elite distance athletes. Int J Sport Nutr Exerc Metab. 2018;28(4):403–11.

    Article  CAS  PubMed  Google Scholar 

  33. Rosenvinge JH, Dasa MS, Kristoffersen M, Pettersen G, Sundgot-Borgen J, Sagen JV, et al. Study protocol: prevalence of low energy availability and its relation to health and performance among female football players. BMJ Open Sport Exerc Med. 2022;8(1):e001219.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Carter JV, Pan J, Rai SN, Galandiuk S. ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves. Surgery. 2016;159(6):1638–45.

    Article  PubMed  Google Scholar 

  35. Saito T, Rehmsmeier M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS ONE. 2015;10(3): e0118432.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Mullur R, Liu Y-Y, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;5:21.

    Google Scholar 

  37. Loucks AB, Thuma JR. Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab. 2003;88(1):297–311.

    Article  CAS  PubMed  Google Scholar 

  38. Logue DM, Madigan SM, Melin A, Delahunt E, Heinen M, Donnell S-JM, et al. Low energy availability in athletes 2020: AN updated narrative review of prevalence, risk, within-day energy balance, knowledge, and impact on sports performance. Nutrients. 2020;12(3):835.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Van Gent R, Siem D, van Middelkoop M, Van Os A, Bierma-Zeinstra S, Koes B. Incidence and determinants of lower extremity running injuries in long distance runners: a systematic review. Br J Sports Med. 2007;41(8):469–80.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lopes AD, Hespanhol LC, Yeung SS, Costa LOP. What are the main running-related musculoskeletal injuries? Sports med. 2012;42(10):891–905.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Ekstrand J, Hägglund M, Waldén M. Injury incidence and injury patterns in professional football: the UEFA injury study. Br J Sports Med. 2011;45(7):553–8.

    Article  CAS  PubMed  Google Scholar 

  42. Bonci CM, Bonci LJ, Granger LR, Johnson CL, Malina RM, Milne LW, et al. National athletic trainers’ association position statement: preventing, detecting, and managing disordered eating in athletes. J Athl Train. 2008;43(1):80–108.

    Article  PubMed  PubMed Central  Google Scholar 

  43. McHaffie SJ, Langan-Evans C, Morehen JC, Strauss JA, Areta JL, Rosimus C, et al. Carbohydrate fear, skinfold targets and body image issues: a qualitative analysis of player and stakeholder perceptions of the nutrition culture within elite female soccer. Sci Med Footb. 2022;5:89.

    Google Scholar 

  44. Jonvik KL, Torstveit MK, Sundgot-Borgen J, Mathisen TF. Do we need to change the guideline values for determining low bone mineral density in athletes? J Appl Physiol. 2022;132(5):1320–2.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Dasa MS, Friborg O, Kristoffersen M, Pettersen G, Sundgot-Borgen J, Rosenvinge JH. Accuracy of tracking devices’ ability to assess exercise energy expenditure in professional female soccer players: implications for quantifying energy availability. Int J Environ Res Public Health. 2022;19(8):4770.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Woods AL, Rice AJ, Garvican-Lewis LA, Wallett AM, Lundy B, Rogers MA, et al. The effects of intensified training on resting metabolic rate (RMR), body composition and performance in trained cyclists. PLoS ONE. 2018;13(2):e0191644.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Parker LJ, Elliott-Sale KJ, Hannon MP, Morton JP, Close GL. An audit of hormonal contraceptive use in Women’s Super League soccer players; implications on symptomology. Sci Med Footb. 2022;6(2):153–8.

    Article  PubMed  Google Scholar 

  48. Dasa MS, Kristoffersen M, Ersvær E, Bovim LP, Bjørkhaug L, Moe-Nilssen R, et al. The female menstrual cycles effect on strength and power parameters in high-level female team athletes. Front Physiol. 2021;3:12.

    Google Scholar 

Download references

Acknowledgements

The authors would like to thank Lise B. Gundersen, Department of Safety, Chemistry and Biomedical laboratory sciences, Western Norway University of Applied Sciences, for consultancy related to storage of biomedical materials. We would also like to thank the female football players, coaches, and staff, who made this study possible, as well as the Western Norway University of Applied Sciences for the providing of research facilities.

Funding

Open access funding provided by UiT The Arctic University of Norway (incl University Hospital of North Norway). The study received funding from the Tromsø Research Foundation and UiT – The Arctic University of Norway.

Author information

Authors and Affiliations

  1. Department of Health and Care Sciences, UiT – The Arctic University of Norway, Tromsø, Norway

    Marcus S. Dasa & Gunn Pettersen

  2. Department of Psychology, UiT – The Arctic University of Norway, Tromsø, Norway

    Oddgeir Friborg & Jan H. Rosenvinge

  3. Department of Sport, Food and Natural Sciences, Western Norway University of Applied Sciences, Bergen, Norway

    Morten Kristoffersen

  4. Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway

    Jørn V. Sagen

  5. Department of Clinical Sciences, University of Bergen, Bergen, Norway

    Jørn V. Sagen

  6. Institute of Sports Medicine, Norwegian School of Sports Sciences, Oslo, Norway

    Jorunn Sundgot-Borgen

Authors
  1. Marcus S. Dasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oddgeir Friborg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Morten Kristoffersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gunn Pettersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jørn V. Sagen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jorunn Sundgot-Borgen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jan H. Rosenvinge
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MSD, OF, GP, MK, JSB and JHR prepared and designed the study. MSD and MK completed the data collection. OF, MSD and JVS completed the data analysis. MSD and OF prepared manuscript draft. MSD, OF, MK, GP, JSB, JVS and JHR edited and approved the final version of the manuscript.

Corresponding author

Correspondence to Marcus S. Dasa.

Ethics declarations

Ethics Approval and Consent to Participate

The study was approved by the Norwegian Center for Research Data (NSD 807592) and was conducted according to the declaration of Helsinki. All handling and storage of biomedical material was approved by the Regional Committee for Medical and Health Research Ethics (REK 2016/787). All players signed a written consent form before partaking in the study.

Consent for Publication

Not applicable.

Competing Interests

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dasa, M.S., Friborg, O., Kristoffersen, M. et al. Evaluating the Suitability of the Low Energy Availability in Females Questionnaire (LEAF-Q) for Female Football Players. Sports Med - Open 9, 54 (2023). https://doi.org/10.1186/s40798-023-00605-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40798-023-00605-4

Keywords